Topics
Imaging and Visualization in Retina
DME Resource Center: Beyond the Clinical Trials: Treatment of DME With Steroids
Supported by advertising from Allergan and Carl Zeiss Meditec
View Insert
Basic Principles of MicroPulse Lasers
Sponsored by Quantel Medical
Endpoint Management: Non-Damaging Laser Therapy of the Macula
Sponsored by Topcon
An Update on the Latest Clinical Trials on DME: Are They Applicable to Other Disease States?
Supported via advertising by Regeneron
DME: Focus On Multiple Targets
Supported via advertising by Allergan and OptoVue
Vitreoretinal Surgery Then & Now
Sponsored by Alcon
View Supplement
The Future of Retina Is Now
DME Resource Center: Beyond the Clinical Trials: Dexamethasone Implant vs. Bevacizumab Injection for Treatment of DME
Diabetic Macular Edema: The Role of MicroPulse Laser Therapy in the Anti-VEGF Era
Sponsored by IRIDEX
Anti-VEGF Therapies and Ocular Systemic Impact Update
Supported through an unrestricted educational grant by Regeneron Pharmaceuticals.
Vitreoretinal Surgery
Transitions Into Clinical Practice for Retina Specialists
This activity is supported by independent educational grants from Allergan, Inc., Genentech, Inc., and Regeneron Pharmaceuticals, Inc.
Anti-VEGF Update: When is Switching Patients Acceptable and Preferable?
The Complex World of Therapeutics
Maximizing Patient Outcomes in DME: A Discussion of Evolving Evidence-Based Options for Clinical Practice
Supported via advertising by Allergan and Optos
Clinical Case Compendium
Supported via advertising by Alcon and Heidelberg Engineering
AMD, RVO, & DME Update: Case Studies in Patient & Practice Management
Beyond the Anti-VEGF Paradigm
The Synergetics VersaVIT 2.0 Vitrectomy System Provides Improved Control and Precision
Sponsored by Synergetics
Diabetic Macular Edema: Understanding and Implementing Findings From Protocol T
Supported via advertising by Regeneron and Heidelberg Engineering
New Paradigms in DME Diagnosis and Management
Diabetic Eye Disease
New Paradigms in the Management and Treatment of Diabetic Macular Edema
Supported through an unrestricted educational grant by Allergan.
Emerging Concepts
Beyond the Clinical Trials: Inconsistent Patient Follow-Up May Affect Outcomes
Supported by advertising from Allergan Inc., and Heidelberg Engineering
Current Insight Into Retinal Disease Management: Focus on DME and Intravitreal Corticosteroids
Retina 2014 – Highlights and Hallmarks
Supported by an educational grant from Regeneron Pharmaceuticals.
Guidance for the Clinical Management of Myopic Choroidal Neovascularisation: The Earlier, the Better
Sponsored by Novartis Pharmaceuticals
Ranibizumab: Expanding Horizons in Retinal Vein Occlusion Management
Sponsored by Novartis Pharma AG
Controversies in Vitreoretinal Surgery
Making the Jump to MicroPulse Laser Therapy for Treating the Macula
Retina in 3-D: A Look Into the Future of Diagnostics, Drugs, and Devices
Supported by advertising from Regeneron Pharmaceuticals
Beyond the Clinical Trials: The Role of Imaging in Patients with DME
Anti-VEGF Therapy for Diabetic Macular Edema
Free Print Subscription
Email Newsletter
Conference Calendar
April 17, 2026
Phase 1 Data for Vamikibart Published in JAMA Ophthalmology
MeiraGTx Announces the Acquisition of XLRP Therapy From J&J
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program
